Plan and produce medical device marketing that reflects the device’s intended use, customer-approved claims, evidence, audience, channel and review workflow. Rudrriv can support launch planning, campaign content, digital channels, distributor enablement and reporting without treating regulated approval as a marketing task.
*Where the device, jurisdiction and customer approval allow patient-facing communication.
Medical device marketing is difficult to price responsibly from a generic rate card because product type, target market, audience, claims, evidence, channel mix and approval workflow can materially change the work. Each option below is scoped as a Custom Quote after requirement review.
For a new device, newly commercialised market, approved line extension or a structured launch reset.
For teams that already know the device and market but need coordinated production across selected channels.
For an established marketing function that needs recurring execution, content production and reporting support.
Share the intended market, audience, campaign goal and the type of assets or channels you need. Rudrriv can review the requirement before confirming scope, commercial model and delivery expectations.
The marketing team may be selling into long clinical and procurement journeys while also working under product-specific claim boundaries, market-specific promotion rules and internal review controls. The page, campaign or sales asset therefore needs to be designed around the actual device and buying context.
Marketing language can influence how a device is understood by clinicians, distributors, procurement teams, patients and regulators. Claims, implied claims, comparisons, visuals and calls to action need to stay aligned with the customer’s authorised product position and supporting evidence.
For the U.S., medical-device labeling and misbranding rules can affect promotional material, while the FTC expects health-related advertising claims to be truthful, non-misleading and appropriately substantiated. In the EU, MDR Article 7 prohibits misleading claims about intended purpose, safety and performance. The customer’s qualified reviewers should determine what is permitted for the exact device and market.
Intended use, approved/cleared claims, labeling, evidence and contraindication/warning context may affect what the marketing can say.
Clinical users, economic buyers, procurement, IT/security, executives and distributors can influence the same purchase.
Audience, channel, device status and local promotion rules can change how a campaign is planned across countries.
Marketing often needs consolidated review from product, regulatory, medical, legal, sales or distributor stakeholders before release.
Scope can be focused on one deliverable or coordinated across the full commercial journey. The mix below is selected according to device, market, audience, channel access and customer review requirements.
Value proposition, audience messaging, proof points and message hierarchy grounded in customer-approved product context.
Launch sequence, content needs, channel roles, review timing, campaign dependencies and handoff planning.
Product pages, campaign pages, resource hubs and conversion paths written for the intended buyer and approved message.
Product overviews, clinical-use context supplied by the customer, sales aids, email copy and educational support assets.
Partner messaging, campaign kits, product content, email assets and launch material aligned to the approved source set.
Search-led topic planning, content production, product education pages and technical-content briefs within agreed claims.
Campaign planning, ad copy, landing pages and reporting where device, market and platform healthcare policies permit.
Lead nurture, distributor communication, event follow-up and lifecycle content for the agreed customer journey.
Pre-event, on-site and follow-up campaign content around product demonstrations, meetings, booth traffic or partner activity.
Measurement plans, campaign dashboards, source tracking and optimisation backlogs based on available marketing data.
A strong medical device campaign is easier to maintain when the team can see which messages come from which approved or customer-supplied sources, who reviews each asset and what changes were requested.
Rudrriv can structure a message and asset workflow around the materials the customer provides. This reduces the risk of copy drifting from intended-use language or evidence during repeated campaign production.
| Marketing object | Useful customer inputs | Rudrriv support | Customer approval remains responsible for |
|---|---|---|---|
| Product webpageCommercial product explanation | Intended use, approved claims, IFU/labeling references, evidence links | Information architecture, copy, UX, CTA and production | Claim permissibility, risk/warning language and final release approval |
| HCP assetClinical-user communication | Approved clinical data, use context, product specifications, references | Content hierarchy, copy, visual brief and version control | Clinical interpretation and medical/regulatory sign-off |
| Paid campaignAd + destination page | Permitted audience, geography, claim set, platform constraints | Campaign structure, copy, landing-page alignment and reporting | Whether promotion is allowed for the device and market |
| Distributor kitPartner enablement | Market status, approved assets, commercial offer, channel rules | Partner messaging, reusable content and campaign kit | Local distribution, regulatory and commercial approvals |
Medical device demand often moves through clinical evaluation, economic justification, procurement, implementation, distributor support or patient education. The content should match the decision the audience is actually making.
Need a clear view of intended use, workflow relevance, evidence, product performance context and practical use considerations.
May need commercial, operational, implementation, service and economic information beyond clinical interest alone.
Need repeatable product messaging and campaign assets that stay consistent across territories and sales teams.
Where permitted, need understandable product information without overstating benefit, minimising risk or implying uses outside the authorised context.
Not every project needs every input, but medical device marketing becomes much more efficient when the source material and approval ownership are clear before production starts.
The workflow below can be shortened for a focused deliverable or expanded for a launch or retained program.
Confirm device, market, audience, objectives, source material and review owners.
Map who discovers, evaluates, influences, approves or buys the product.
Build approved-claim, proof-point and CTA structure for each audience.
Create the agreed web, campaign, content, email or sales-enablement assets.
Route through customer review, apply consolidated comments and control versions.
Deliver final assets, source files as agreed, launch notes and measurement setup.
The exact deliverable set is confirmed in the statement of work. These are common output types for a medical device marketing engagement.
Audience, objectives, channel roles, content priorities, timing and dependencies.
Audience-specific value proposition, proof points, objections, CTA and source references.
Marketing messages organised against customer-provided references and review status.
Copy, layouts or content files for the agreed website, landing, email or campaign scope.
Reusable product messaging and campaign material for internal or channel teams.
Planned topics, formats, audience, stage, source needs and review timing.
KPIs, source tracking, reporting cadence and optimisation backlog based on available data.
Approved final files, editable/source formats where agreed, version notes and implementation guidance.
Boundary clarity is important in medical devices because marketing, regulatory, clinical, legal, reimbursement and commercial responsibilities can sit close together but are not the same service.
Platform access is requested only when needed for agreed execution. Logos are not shown because this section describes system categories, not partnerships.
Product pages, resources and campaign destinations.
Lead stages, sales handoff and campaign source data.
Nurture, distributor, event and lifecycle sequences.
Where device and platform healthcare policies permit.
Traffic, conversion, campaign and source reporting.
Customer document, DAM or approval tools as required.
For medical devices, useful quality checks include source alignment, audience fit, version control, digital QA and customer approval checkpoints as well as ordinary copy and design review.
Revision rounds refine the agreed deliverable using consolidated feedback. Customer regulatory, medical and legal reviewers can comment within the agreed workflow, but a revision does not automatically include a new market, new audience, new indication, new campaign objective or materially expanded asset set.
These are practical situations rather than case-study claims. The required scope depends on what is already approved, built and ready to use.
A device is approaching a market-ready stage and marketing needs a launch plan, message hierarchy, asset list and review schedule.
The same product is entering another geography and the team needs market-specific audience, content and approval planning.
Partners need consistent approved messaging and reusable campaign material instead of creating independent local copy.
Legacy marketing no longer reflects the current product, evidence, buyer journey or approved commercial message.
The first step is a scope review, not an assumption that every medical device marketing project should use the same package.
These answers describe the marketing service boundary. Your qualified regulatory, medical, legal and clinical reviewers should determine requirements for the exact device and jurisdiction.
It can include market and audience planning, positioning and messaging, launch planning, website and landing-page content, campaign creative, HCP and distributor materials, SEO and content programs, paid-media planning, email and CRM content, conference support, sales-enablement assets, and reporting. The exact scope depends on the device, intended use, market, audience, channel and review requirements.
No. Rudrriv can organise marketing content around client-supplied intended-use statements, approved or cleared claims, evidence and review comments, but regulatory, medical, legal and clinical approval remains with the customer and its qualified reviewers.
Rudrriv can support planning, research, messaging frameworks and launch preparation before commercial readiness where appropriate. Public promotion and market-facing claims must follow the rules applicable to the target jurisdiction and the customer’s regulatory direction.
Yes, where the device and jurisdiction permit it. The content path should be separated by audience because clinicians, procurement teams, distributors, patients and caregivers need different evidence, language, calls to action and review controls.
Useful inputs include the device description, intended use, approved or cleared claim language, labeling or IFU material, evidence selected by the customer, target markets, buyer groups, channel plan, brand assets, existing content, internal approval workflow and any fixed launch or conference dates.
Not for a normal initial scope review. Avoid sending patient-identifiable or highly sensitive data in the enquiry form. If a later analytics or CRM project requires sensitive information, data handling and access requirements should be separately reviewed and agreed before work begins.
The workflow can be structured around customer review checkpoints. Rudrriv can incorporate consolidated comments and maintain a clear change trail, while the customer’s qualified reviewers remain responsible for approval decisions.
Depending on scope, deliverables can include a campaign or launch plan, messaging matrix, audience and journey map, claim-to-source tracker, web copy, campaign content, creative specifications, channel plan, sales-enablement content, launch checklist, reporting framework and editable source files where agreed.
This page uses Custom Quote pricing because device class, target market, number of products, number of audiences, content volume, channel mix, evidence review, stakeholder approvals and ongoing management can materially change the work. Scope and price are confirmed after the requirement is reviewed.
Delivery time is confirmed after scope review. Timing depends on the number of assets and channels, content and evidence readiness, stakeholder availability, regulatory or medical review cycles, revision rounds, third-party dependencies and fixed launch or event dates.
Yes, as a custom scope. Multi-market work generally requires separate consideration of approved claims, language, audience, channel restrictions, local market practices and customer review responsibility for each geography.
Paid-media planning and management can be scoped where the device, market and platform permit advertising. Platform healthcare policies, destination-page requirements and geographic restrictions may affect what can run. Media spend is normally separate from the service fee unless explicitly included.
No. Clinical research, regulatory submissions, clinical evaluation and the creation of scientific evidence are outside standard marketing scope. Rudrriv can work with evidence and source material supplied or approved by the customer for marketing production.
Yes. Distributor and sales enablement can include value propositions, product overviews, objection-handling content, campaign kits, email sequences, landing-page copy and asset libraries, provided the content remains within the customer-approved claims and use context.
Revisions are used to refine the agreed deliverables against consolidated customer feedback and review comments. New indications, new audiences, new markets, substantial claim changes or materially expanded deliverables can require a scope change.
Unless separately agreed, standard scope does not include regulatory approval, legal advice, clinical advice, clinical research, product certification, medical-device registration, reimbursement consulting, media spend, conference booth fabrication, specialist software licenses or guaranteed commercial outcomes.
Email ID, Phone and Requirement Details are required. Name is optional.
